1. Home
  2. TNXP vs SBFG Comparison

TNXP vs SBFG Comparison

Compare TNXP & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$13.32

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Logo SB Financial Group Inc.

SBFG

SB Financial Group Inc.

N/A

Current Price

$29.20

Market Cap

164.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TNXP
SBFG
Founded
2007
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
164.8M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
TNXP
SBFG
Price
$13.32
$29.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
486.9K
11.0K
Earning Date
05-11-2026
04-23-2026
Dividend Yield
N/A
2.98%
EPS Growth
91.75
27.33
EPS
N/A
1.41
Revenue
$13,107,000.00
N/A
Revenue This Year
$558.11
N/A
Revenue Next Year
$38.29
N/A
P/E Ratio
N/A
$20.39
Revenue Growth
29.85
N/A
52 Week Low
$9.40
$18.16
52 Week High
$29.19
$29.15

Technical Indicators

Market Signals
Indicator
TNXP
SBFG
Relative Strength Index (RSI) 57.01 66.26
Support Level $11.98 $20.94
Resistance Level $13.36 N/A
Average True Range (ATR) 0.71 0.90
MACD 0.04 0.12
Stochastic Oscillator 52.17 90.86

Price Performance

Historical Comparison
TNXP
SBFG

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About SBFG SB Financial Group Inc.

SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in a single segment, which is Banking.

Share on Social Networks: